Head to Head Contrast: Agilon Health (NYSE:AGL) vs. XWELL (NASDAQ:XWEL)
by Scott Moore · The Cerbat GemAgilon Health (NYSE:AGL – Get Free Report) and XWELL (NASDAQ:XWEL – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.
Volatility & Risk
Agilon Health has a beta of 0.33, indicating that its stock price is 67% less volatile than the S&P 500. Comparatively, XWELL has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.
Profitability
This table compares Agilon Health and XWELL’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Agilon Health | -6.60% | -120.82% | -24.89% |
| XWELL | -51.85% | -352.37% | -64.88% |
Valuation & Earnings
This table compares Agilon Health and XWELL”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Agilon Health | $5.93 billion | 0.05 | -$391.35 million | ($23.75) | -0.78 |
| XWELL | $29.21 million | 0.26 | -$16.85 million | ($5.11) | -0.26 |
XWELL has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than XWELL, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
8.7% of XWELL shares are held by institutional investors. 2.3% of Agilon Health shares are held by company insiders. Comparatively, 13.9% of XWELL shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings and target prices for Agilon Health and XWELL, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Agilon Health | 2 | 10 | 3 | 0 | 2.07 |
| XWELL | 1 | 0 | 0 | 0 | 1.00 |
Agilon Health currently has a consensus target price of $51.93, suggesting a potential upside of 180.25%. Given Agilon Health’s stronger consensus rating and higher possible upside, equities analysts plainly believe Agilon Health is more favorable than XWELL.
About Agilon Health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
About XWELL
XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.